Dr. Tiffany Tanaka from the University of California, San Diego explains the development of High-Risk MDS into AML. She talks about new diagnostic and treatment regimens for these patients.
🚨 Give the Gift of Answers, Support, and Hope 🚨
Make a donation before ✨midnight✨ on December 2nd and see your generosity go twice as far.